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Dimitra Angelidou, RN
A B S T R A C T
Patients with implanted cardiac devices constitute a growing segment of the contem-
porary healthcare practice. Taking care of such a rapidly growing patient population 
constitutes a challenge for all health care providers working in a cardiology ward, 
operating or procedure room, or primary care practice. Nurses among them have a 
unique role by being the most appropriate persons to provide in-hospital and long-
term health care, education and psychological support to these patients. In-hospital 
and long-term care will ensure an uneventful procedure and a safe discharge as well as 
early detection of device malfunction and late complications. Education of the patient 
will prevent any self or environmental interactions which can adversely affect proper 
device function and will increase his or her adherence to the follow-up treatment. Fi-
nally, by providing psychosocial and emotional support the nursing staff can address 
the immediate concerns of the patient and help him or her cope successfully with the 
new life situation. Continuing education is extremely important for nurses counselling 
patients with implanted devices in order to play successfully their role as the continu-
ous link to the multidisciplinary team of professionals that guide the oftentimes for-
gotten humanistic care of these patients.
I N T R O D U C T I O N
Patients with implanted cardiac devices constitute a growing segment of the con-
temporary healthcare practice. According to the American Heart Association, more 
than 170,000 pacemakers and 30,000 implantable cardioverter-defibrillators (ICDs)1 are 
implanted in the United States each year. Since there were released the results of the 
Multicenter Automatic Defibrillator Implementation Trials (MADIT I and II), which 
found ICD treatment superior to drug therapy alone for the treatment of ventricular 
arrhythmias, the number of implantations of ICDs has quadrupled.2,3 In fact, pacemak-
ers with biventricular pacing capability, many of them combined with ICD function, are 
now being implanted for New York Heart Association Class III and IV heart failure 
patients aiming to improve their quality of life and increase their life expectancy.4 A 
recent study which pooled data from three trials of 1,080 patients found that cardiac 
resynchronization (biventricular pacemaker-based therapy) decreased the risk of death 
from progressive heart failure (often sudden death from lethal arrhythmias) or cardiac 
transplantation compared to the control group by 59%.5
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Similarly, recent data from the registry of the European 
Heart Rhythm Association have shown that, despite the fact 
that ICDs are underused in Europe, device implantation rate 
exhibits an increased trend in most European countries over 
the last few years.6 Taking care of such a rapidly growing 
patient population constitutes a challenge for all health care 
providers working in a cardiology ward, operating or procedure 
room, or primary care practice. Nurses among them have a 
unique role by being the most appropriate persons to provide 
in-hospital and long term health care, education and psycho-
logical support to these patients. In this review we will present 
briefly some of the aspects of the nurse’s role as counselors of 
patients receiving an implantable cardiac device.
I N - h O S p I T A l  A N D  l O N g - T e R m  C A R e  O f 
p A T I e N T S  w I T h  I m p l A N T e D  D e v I C e S . 
T h e  N U R S e ’ S  R O l e
The preoperative, intraoperative and postoperative care is 
similar for all patients regardless of which type of implantable 
cardiac device they receive. In the case of an elective proce-
dure, typically a generator replacement, the patient is admitted 
for an overnight stay. On the other hand, in case of a first-time 
implantation the patient may have already spent several days 
in the hospital undergoing invasive and non-invasive diagnostic 
tests (like coronary angiogram, electrophysiology study, tilt-
table test or Holter monitoring) before the criteria for a device 
implantation have been met. Under these circumstances, 
nurses have the valuable role to closely monitor patient’s vital 
signs and clinical status. This type of close monitoring will allow 
early detection of abnormalities preoperatively, like hemato-
mas or occult infections at the intravenous line sites or excess 
fluid retention in patients with heart failure, which have to be 
thoroughly treated before the procedure. In addition, nurses 
should be kept responsible for the meticulous preparation 
of the patient for the operating or procedure room inserting 
the appropriate lines and administering chemoprophylaxis 
and sedation. Knowledge of these medication dosages and 
adverse effects is also mandatory.7 In the procedure room 
nurses assist the physicians and coordinate the operating room 
tasks performed by the medical team. They assist initially by 
placing monitors, starting IV lines and positioning. They also 
scrub in to pass instruments and assist the operator as well 
as circulating duties that include charting during the case, 
monitoring the patient and communicating with both nurses 
and physicians in the cardiology ward and in the cardiac care 
unit to coordinate the best care for the patient.8 Postoperative 
nurse monitoring is even more important since it will allow 
early detection of surgical complications like hematoma, in-
fection, dysrrhythmias, pneumothorax and hemothorax. The 
continuation of prophylactic antibiotic coverage for at least 24 
hours following devices insertion should also be part of the 
post-implantation nursing care.9
The role of a pacemaker nurse as a member of the follow-
up pacemaker clinic has been established in most European 
countries and the USA. A pacemaker nurse is directly involved 
in the patient follow up evaluation, i.e. history taking, patient 
examination and use of the equipment for analysis of the 
device function, which include 12-lead electrocardiography 
with and without magnet, radiography, ambulatory and tran-
stelephonic electrocardiographic monitoring, and pacemaker 
programmers.10 Specific training in this very demanding field is 
required for the pacemaker nurses to accomplish their duties 
successfully and regular re-training to keep up to date with 
the rapidly evolving changes in the device technology seems 
also mandatory.
Beyond the highly specialized role of a pacemaker nurse, 
any nurse working in a primary health care setting should be 
familiar with at least some general aspects of the pacemaker 
patients’ follow-up care and provide counselling to this patient 
population. For the long-term follow up, patients who have a 
pacemaker or an ICD should always be encouraged to carry 
the manufacturer’s identification card with them at all times. 
In this card as well as in the medical record the following 
information must be documented: (a) the manufacturer of 
the device, (b) the model number, (c) the serial number, (d) 
implant date, (e) mode of operation, (f) programmed param-
eters (output, rate, sensitivity), (g) upper and lower rate limits 
for rate responsive devices, (h) type of lead fixation (active or 
passive), (i) unipolar or bipolar lead system, (j) ICD capability 
(shock, pacing, both), and (k) type of delivery system for ICD 
shocks (epicardial or transvenous lead system). At each clinic 
visit, the nurse should inquire about symptoms indicative of 
arrhythmias, heart failure, and/or ischemia, as well as device 
complications such as the development of dizziness, syncope, 
palpitations, chest pain, and shortness of breath. The patient 
should be specifically queried about arm swelling and increased 
warmth on the side ipsilateral to implantation of the endo-
vascular leads, and redness or swelling at the device pocket.
Reported cardiac device infection rates vary between 2% 
and 8%. Treatment typically involves the removal of all im-
planted hardware, in addition to long-term antibiotic therapy.11 
Patients should always be questioned about ICD discharges 
(shocks) that have occurred between visits, however it is not 
uncommon for ICDs to reach end-of-life without ever deliver-
ing a shock for a clinical event. The nurse should be aware and 
inform the other clinic staff that there is no danger to them if 
they come in contact with a defibrillator patient during an ac-
tive ICD discharge. Unintended effects of antiarrhythmic drugs 
can deplete generator life and lead to device malfunctioning, 
such as firing for sinus tachycardia or atrial fibrillation with 
a rapid ventricular response. Electrolyte imbalances, includ-
ing hyperkalemia or hypokalemia, alter the heart’s electrical 
response and must be avoided. Nurses who are taking care of 
patients with implanted cardiac devices who are also taking 
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antiarrhythmic drugs, need to monitor drug and electrolyte 
levels on a regular basis (every 2 to 3 months). Finally, it is 
a nurse’s duty to ensure that a chest radiograph is obtained 
post-implantation of either a pacemaker or ICD to document 
baseline location and condition and that it should be repeated 
on an annual basis or whenever a lead fracture, lead dislodge-
ment, or migration is suspected.
T e A C h I N g  A  p A T I e N T  w I T h  
A N  I m p l A N T e D  C A R D I A C  D e v I C e
Ideally, patient teaching should start preoperatively and 
include the patient’s family and caregivers. Education is es-
sential for a cardiac device recipient and guidelines for nursing 
care have already been published. The underlying assumption 
is that the patient will process and understand the information 
received to help him/her to adapt his/her life with a device. 
While recovery from these procedures is generally uncompli-
cated, patients need to learn beforehand how to avoid putting 
tension or stress on the leads so that they stay in place. The 
nurse is responsible for instructing the patient to keep the arm 
on the side of the device in a sling for the first day postopera-
tively, even while he sleeps, to completely immobilize it. The 
patient should also instructed that for four to six weeks after 
the implant procedure, he/she should not raise the affected 
arm over the head, lift anything with it, or do any activity that 
requires abrupt, forceful arm movements.12 Another aspect of 
teaching is to make the patient aware about potential com-
plications. He/she should be told to seek care immediately if 
he/she experiences chest pain or shortness of breath. He/she 
should call his/her physician if he/she develops swelling of the 
hands, arms, legs, ankles, or feet, or sudden weight gain, such 
as 1.5 kilograms overnight or up to 3 kilograms over two or 
three days. These signs and symptoms could indicate, among 
other things, worsening heart failure, which could also mean 
that the device is not functioning properly.13 Nurses should 
explain how to spot signs of infection and tell the patient to 
call the physician if the surgical site becomes red, warm, or 
has drainage, or if he/she develops fever.
The nurse taking care of a patient with an implanted device 
makes sure that patient receives the proper identification card 
and carries it in his person all the time. Patients should be 
instructed to show this card to security personnel at airports 
and anywhere where they might have to go through a metal 
detector, and to healthcare professionals before routine exams 
and during emergency care.
Electromagnetic interference (EMI) is another issue patients 
need to be counseled on. The nurse has to be familiar with 
the relevant information to communicate it to the patient. 
Electromagnetic interference is defined as “highly-regular 
electrical potentials of low amplitude and high frequency.” 
Experts feel that sources of EMI must be in close proximity 
(within 1.5 meters) to the patients’ devices in order to interfere 
with cardiac device functioning. Sources carrying the highest 
probability levels of interference with cardiac devices include: 
arc welding equipment, electronic muscle stimulators, radio 
transmitters, concert speakers, large motor-generator systems, 
electric drills, and hand-held metal detectors.14 Dual-chamber 
pacemakers are programmed to be more sensitive to electrical 
stimuli than single-chamber pacemakers, and therefore have 
the highest incidence of EMI. Dual-chamber pacers are also 
more likely to revert to asynchronous, fixed-rate pacing from 
EMI exposure. Pacemaker-dependent persons (those with 
an intrinsic heart rate of less than 30 bpm) are most likely to 
experience signs and symptoms attributable to EMI, or from 
the reversion to asynchronous, fixed-rate pacing. Electronic-
article surveillance systems (the wand-type of surveillance 
often used at airports) affect pacemakers more than ICDs, due 
to the stronger protective-device shielding used in ICDs. In 
2000 a study reported that the interaction between pacemakers 
and electronic-article surveillance systems occurred in 20% 
of dual-chamber pacers and 10% of single-chamber pacers.15
On the other hand EMI may cause inappropriate discharge 
of an ICD. The incidence of inappropriate ICD discharges 
was estimated as less than 1% per patient per year in a study, 
published in 2001, of 341 ICD patients who were followed 
retrospectively over a 3-year period. Interrogation of the 
ICDs revealed instances where defibrillation (device activa-
tion) occurred in the absence of either ventricular tachycardia 
or ventricular fibrillation. After excluding other sources of 
interactions, such as muscle contractions, lead fracture, and 
dislocation of the connector, it was concluded that EMI was 
the sole source of electrical interference. The ICD errone-
ously identified the EMI as a life-threatening arrhythmia and 
delivered a shock.16 The overall number of EMI occurrences 
is likely underestimated; non-sustained episodes of EMI may 
have occurred unbeknownst to the patient or terminated 
spontaneously before the device(s) responded. In addition to 
documented EMI effects, unusual environmental interactions 
with ICDs have occurred, such as during showering, while 
seated at a slot machine, and while using an electric razor. 
Several of the ICD episodes clearly involved EMI, while the 
origin of others is less clear. Older generation ICDs and those 
implanted in the upper abdomen are more likely to be affected 
by EMI than the newer generation ICDs. Better identification 
of 50 to 60 cycle (Hz) interference has improved differentia-
tion of ventricular arrhythmias and rapid patient movement 
from EMI, which lessens the occurrence of inappropriate ICD 
discharges. Similarly, industry advances in pacemaker lead 
technology, such as bipolar sensing and pacer leads dedicated 
to defibrillation instead of integrated bipolar sensing circuits 
have also reduced EMI. Since most of the patients are aware 
of the potential of EMI they often worry about how certain 
electrical equipment and devices will affect their pacemaker or 
ICD. All patients need to be reassured that most devices have 
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features that prevent interference from household appliances, 
including microwaves and office or shop equipment.17 It is also 
safe to pass through metal detectors at airports and electronic 
anti-theft devices used by department stores. While safe to use, 
cell phones should not be carried in a chest pocket directly over 
an implanted device due to the possibility of interference from 
some high-powered digital cell phones. However, machinery 
that contains large magnets or strong electromagnetic fields, 
such as high-voltage electrical transformers, arc welding 
equipment, and high-current industrial equipment, should be 
avoided. A brief catalogue of all potential electrical hazards can 
be very reassuring for most of the patients (Table 1).
Another activity patients need to be counselled about 
postoperatively is car driving. Initially, a patient with an ICD 
will likely be restricted from driving because of the risk of 
injury—to himself and others—if he loses consciousness.18 A 
relevant law does not exist in our country. In the US restric-
tions may vary with state law, and patients may be allowed to 
resume driving if they go for a prolonged period—six months 
or one year—without receiving a shock, or without fainting 
when they are shocked. Relevant guidelines have been issued 
by the American Heart Association19 and the European Society 
of Cardiology.20
Finally, regardless of which type of device the patient has, 
the importance of taking all medications as prescribed needs 
to be emphasized. The nurse counsellor must explain that 
antiarrhythmics and other drugs work in conjunction with 
pacemakers and ICDs to help control the heart’s rhythm and 
remind patients that those with pacemakers need to follow-up 
with their cardiologist once or twice each year, while those with 
ICDs may need to do so once every three to six months. At 
these visits, the physician will check the device’s settings, collect 
information stored in its memory, and adjust its programming 
if necessary. The patients with advanced heart failure and a 
biventricular pacemaker should be specifically instructed to 
continue their follow-up with both a heart failure specialist 
and an electrophysiologist.
p S y C h O l O g I C A l  S U p p O R T  f O R 
p A T I e N T S  w I T h  A N  I m p l A N T e D 
C A R D I A C  D e v I C e
The majority of patients who are implanted with a device 
experience a desirable quality-of-life and a high acceptance 
rate especially when their symptoms improve postoperatively. 
More specifically, the group of patients with a VVI or DDD 
pacemaker report an acceptable health related quality of life. 
Nevertheless, a recent Swedish study showed that the most 
socially vulnerable groups of the pacemaker population like 
women, single persons, as well as elderly and retired persons 
experience worsening of their life status after a pacemaker 
implantation.21 On the other hand, 30 to 50% of patients who 
had an ICD implanted reported some degree of negative effect, 
such as fear, anxiety, and depression.22 Additionally, lifestyle 
changes that affect driving, sexual activity, social interactions, 
physical appearance and physical activity further complicate 
the life of the recipient. Younger implanted patients, some as 
young as 4 years of age, those <50 years of age, and those who 
experience high rates of shocks have been identified as being 
at special risk for development of psychological distress and 
poor health outcomes.23
The major psychosocial concerns, no matter what the age 
of the patient, include device dependency, fear of shock, poor 
body image, device malfunction, significant lifestyle changes, 
unpredictability of therapy, and isolation. These concerns may 
translate into anxiety disorder, depression, shock expectancy, 
post traumatic stress disorder, panic attacks, and phobias.24 It 
appears that anxiety and depression increase with the frequen-
cy of shock episodes for the patients who carry an ICD. Anxiety 
about the ICD firing is closely associated with the occurrence 
of depression, while avoidance of activities is associated with 
anxiety.25 “Worry” about the ICD and a belief that ICD firing 
can be predicted is associated with anxiety sensitivity. The 
patient develops a belief that shock can be predicted. Monitor-
ing of signs of impending shock begin to increase. This leads 
to hypervigilance regarding body sensations that are often 
provoked by anxiety. This can lead to increased awareness 
of body sensations, which in turn may lead to the individual 
associating unrelated chance sensations with shock.26 When 
a patient feels anxious or depressed, he also begins to feel 
less secure and less satisfied with the ICD therapy and report 
a decrease in quality of life. The resulting anxiety promotes 
increased avoidance behaviour, fear of increasing autonomic 
TABle 1. Main Sources of Electromagnetic Interference 
with Implantable Cardiac Devices
electrical hazards 
to be aware of
electrical hazards 
to avoid
electrical 
appliances that are 
okay to be around
Cellular Phones Working under the 
hood of a running 
car
Microwave ovens
Theft detection 
devices
MRI (magnetic 
resonance imaging)
Hair dryers
Electrocautery – in 
the operating room 
or in the dentist’s 
office
Electric blankets 
and heating pads
Arc welding Computers
Therapeutic 
radiation
Radios, TVs and 
stereos
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arousal, sleep disturbances, sexual dysfunction, increased ir-
ritability and difficulty concentrating.
Researchers27,28 agree that psychological and emotional 
support for the patient with an implanted device is an impor-
tant aspect of care that has not been given as much attention 
as is needed. Providing the implanted patient time to verbal-
ize fear or concerns related to the device, as well as allowing 
discussion of the meaning of his or her illness, is an important 
aspect of a psychological plan for these patients. The nursing 
staff as part of the team taking care of the patient with an im-
planted device should give information concerning the device 
implant as soon as the recipient is informed that the device 
is necessary. The patient should be provided an opportunity 
to see and hold a device replica in order to see what it looks 
and feels like. Patients need to be taught what to expect im-
mediately post-operatively, during recovery, long-term effects, 
and any limitations that will be present post-implant. Patient’s 
questions concerning sexual activity, anxiety and guilt, device 
failure and potential death must be dealt with openly and hon-
estly. The family of the patient must be included in this educa-
tion process. Families of the patient experience some of the 
same fear and anxiety felt by the device recipient. Reports of 
parents of children with implants becoming overprotective and 
spouses exhibiting hypervigilant behaviour have been widely 
reported.29 Teaching coping skills related to ICD discharge, 
and increasing knowledge and understanding of the disease 
process that precipitates the need for the device, provides the 
patient with a degree of control. Interventions of this type also 
facilitate self-management. Eads et al.30 have suggested using 
seven unique principles to facilitate psychosocial adjustment 
during routine follow-up visits for patients with an ICD. These 
seven principles, which can easily be adopted also for the pa-
tients who carry a pacemaker or a cardiac resynchronization 
device, are:
1 .  D e f I N e  T h e  p R O B l e m
Allow the patient to pinpoint specific concerns. Some 
specific concerns that would not ordinarily be identified are 
memory difficulties, difficulty sleeping, overprotective family, 
and sexual difficulties, as well as depression, fear of shock, 
and fear of device malfunction. Questioning patients about 
personal concerns during routine follow-up visits gives an 
opportunity to attain needed information, express feelings, 
and simply chat about the device. Patients need a chance to 
tell their story. Questions such as “What are your concerns 
about having a pacemaker/ ICD?” and “Are you worried about 
your pacemaker/ICD?” may stimulate discussion between the 
pacemaker/ICD clinic staff and the patient.
2 .  p R O v I D e  I N f O R m A T I O N
This may be one of the most effective methods of increasing 
a sense of control. Patients who felt better prepared for living 
with the device after implantation had better medical and 
psychosocial outcomes. On the other hand, erroneous beliefs 
about the device may result in counterproductive behaviour, 
such as attempts to predict shock or activities that are believed 
to induce shock. For some patients, this may translate into a 
debilitating pattern consisting of progressive limitations in 
activities and escalation of fearful thoughts. Ongoing patient 
contact, along with medical knowledge and expertise, puts the 
nursing staff in an exceptional position to provide information 
to enhance patient perceptions of control over reactions to 
their medical diagnosis. Typically, targets of education for 
the patient comprise explanations about the medical condi-
tion, device function and action, and discussions about life-
style change that come about as a result of the implant. For 
example, fear of triggering the device during sexual activity 
is a fear in approximately 50% of patients. Addressing this 
subject directly is important. Sex is a natural part of life, and 
this type of physical exertion is particularly anxiety-provoking 
for patients. It is typically related to the erroneous assumption 
that sexual activity represents an extreme level of exertion. In-
terventions may normalize feelings about sexual activity. Nurse 
counselling a patient with an implanted device may provide 
education regarding safe levels of sexual activity. Discussing 
the role of regular exercise may lead to increased confidence 
about engaging in sex. Information concerning other sources 
of sexual dysfunction, i.e., medications and vascular disease, is 
also important. Starting the discussion with the question “Do 
you have any questions for me about the pacemaker/ICD?” 
may be a good way to engage use of this principle.
3 .  C R e A T e  T e A m  S U p p O R T
Social support is a significant enhancement to adjusting to 
cardiac illness. Ensuring trusting and supportive relationships 
with family and friends on whom the device patient can depend 
is important for adjusting to the implant. It is important to 
note that healthcare providers are psychosocial providers and 
significant sources of support to this patient group. Patients 
especially value the relationship that is developed with the 
people who fully understand their needs. Even so, patients may 
still need an invitation to talk about and express their needs; 
therefore, open communication is very important. Open this 
discussion with “We would like you to think of yourself as part 
of your treatment team.”
4 .  N O R m A l I z e  f e A R S
Approximately 13–38% of ICD patients experience diag-
nosable levels of anxiety, and nearly one-third report fear of 
shock. ICD shock can be extremely uncomfortable, and those 
patients who receive more than one shock consecutively may 
be at risk for a high incidence of psychosocial complications. 
Engaging the ICD patients in discussion that normalizes 
emotions enables the follow-up staff to help the patients talk 
about their fears and other reactions relating to the ICD. The 
follow-up staff can then assure patients that fear is an expected 
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part of having an ICD implant and is neither a sign of poor 
outcome nor an abnormal occurrence. When fear is labelled 
as a safe and inevitable part of treatment, patients become less 
sensitive to the presence of fear. Accepting fear may enhance 
the patient’s confidence to resume a normal life despite the 
threat of shock. The statement “Feeling stressed about the 
device is a normal reaction” may spark this discussion.
5 .  e N C O U R A g e  e m O T I O N A l  R e l e A S e
Patients who avoid talking about the negative aspects of 
their device are at increased risk of ongoing emotional dis-
tress. Merely affording a patient the opportunity to discuss 
worrisome issues with an open and empathic listener allows 
for emotional catharsis. Asking “Can we discuss your feelings 
about your device?” may lead to relief from the burden of har-
bouring unexpressed concerns, and may precede resolution of 
uncertainties connected with the device. As important as this 
principle is, implementation is time-intensive. The nursing staff 
might consider allowing brief discussion periods with the pa-
tient on a routine basis, which may help in decreasing extreme 
emotional outburst that take more time with which to deal.1
6 .  A  S T A T e m e N T  S U C h  A S  “ I T  I S  p O S S I B l e  
T O  R e T U R N  T O  y O U R  N O R m A l  A C T I v I T I e S 
A f T e R  y O U  R e C O v e R ”  w I l l  I N S T I l l  h O p e
It is very important to assure the implanted patients that 
the physical discomfort and emotional distress they are experi-
encing will more than likely diminish with time. Overall, quality 
of life and psychosocial functioning in the areas of emotional 
behaviour, alertness, and social interaction temporarily decline 
six months post implant. Follow-up studies at 12 months have 
found that all areas of functioning return to baseline.
7 .  e N C O U R A g e  p A T I e N T S  T O  T A K e  A C T I O N
The follow-up staff can effectively foster self-efficacy be-
haviours in patients by providing instruction about self-care 
and by encouraging the belief that patients possess the capacity 
to successfully care for themselves. It is psychologically enhanc-
ing for patients to resume everyday activities after receiving 
the device. There are times patients may need encouragement 
to maintain a degree of physical exertion over time, including 
exercise or sexual activity.
Other approaches for psychosocial intervention of the 
patient implanted with a cardiac device have also been im-
plemented. One such approach is the initiation of cognitive 
behavioural therapy31 while alternative therapies such as 
progressive muscular relaxation, breathing techniques, deep 
relaxation, and self hypnosis, taught early and re-enforced 
through out follow-up, have helped the patient cope with the 
new stress of an implant.32 However, regardless of the type 
of intervention chosen to offer psychosocial and emotional 
support to the recipients of an implantable cardiac device, 
the role of the nurses as educators and advocates for this 
unique and challenging population is extremely important, 
and are the continuous link to the multidisciplinary team of 
professionals that guide the oftentimes forgotten humanistic 
care of these patient.33
C O N C l U S I O N S
With more and more patients receiving pacemakers, ICDs, 
and combination devices, a need for multidisciplinary approach 
to meet these population-specific needs becomes obvious. 
Nurses who have a holistic outlook on patient care can play a 
key role in this health care team by supporting these patients 
and their families during as well as after implantation. To ac-
complish this task nursing intervention must be multi-level. 
In-hospital and long-term care will ensure an uneventful pro-
cedure and a safe discharge as well as early detection of device 
malfunction and late complications. Education of the patient 
will prevent any self or environmental interactions which can 
adversely affect proper device function and will increase his/
her adherence to the follow-up treatment. Finally, by provid-
ing psychosocial and emotional support the nursing staff can 
address the immediate concerns of the patient and help him/
her cope successfully with his/her new life situation. To be able 
to meet the requirements of this complex role is essential that 
nurses taking care of patients with implanted devices receive 
training and continuing education in this rapidly evolving field.
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